The Latest Breaking News from BofA

Pinterest stock slips despite reporting better-than-expected revenue and user growth in Q2. BofA analyst says PINS shares could climb significantly to $44.

It all comes down to the labor market, immigration, and tariffs. What is really going on in terms of how many workers are available?

Super Micro stock tanks on disappointing Q4 earnings and weaker-than-expected guidance. Here’s why SMCI shares aren’t worth buying on the post-earnings decline.

“This implies that the weak gains in payrolls in recent months might have something to do with the supply of labor.”

Ford Motor Company (NYSE:F) shares are trading higher on Thursday after the automaker posted second-quarter results that exceeded Wall Street expectations on Wednesday, driven by solid vehicle volumes and favorable pricing trends.

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

“Today a confluence of factors argue that the key tail risk that may not be priced in is not just a cyclical recovery, but a boom,” BofA Research analysts write.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) announced Monday it will voluntarily and temporarily pause all U.S. shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, effective July 22.

Is BofA’s Q2 revenue miss just a brief pause? Or a warning sign to rethink your position?

"A technology that can perform endless complex calculations in zero-time, warp-speeding human knowledge and development."

Morgan Stanley (NYSE:MS) on Wednesday reported a second-quarter 2025 earnings of $2.13, up from $1.82 a year ago and beating the consensus of $2.02.